『ImmunoCAST』のカバーアート

ImmunoCAST

ImmunoCAST

著者: Thermo Fisher Scientific
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
From medical guidelines and best practices to educational insights on specific disease states, ImmunoCAST is a podcast dedicated to providing healthcare providers of all specialties clinically relevant, easy-to-digest episodes on allergy related topics.Copyright 2026 ImmunoCAST 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • New HEDIS Measures for Asthma: What Clinicians Should Know
    2026/10/12
    New HEDIS measures are changing the expectations around asthma follow-up, creating an important opportunity for primary care providers to look beyond the exacerbation itself. This episode explores the 2026 HEDIS Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E) measure and what clinicians should consider assessing during that critical 30-day follow-up. We discuss asthma control, medication adherence and inhaler technique, environmental and allergic triggers, specific IgE testing, and how clinical history plus testing can help determine whether allergic sensitization is relevant. The conversation also examines the relevance of COPD and asthma, including overlapping disease features and upcoming changes to COPD HEDIS measures. Learn how to turn evolving quality measures into a clinically meaningful follow-up that can help clarify what contributed to an exacerbation and inform more targeted long-term patient management. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/asthma-hedis-follow-up-specific-ige-copd.html?cid=0ct_3pc_05032024_9SGOV4
    続きを読む 一部表示
    25 分
  • When Food Allergy Meets Food Insecurity
    2026/09/21
    More than 1 in 4 children with food allergy live in food-insecure families, highlighting a challenge that extends well beyond allergen avoidance. This episode explores how food insecurity, socioeconomic status, access to care, insurance coverage, geographic barriers, medication affordability, and access to allergen-free foods can affect food allergy management and quality of life. The conversation covers diagnostic accuracy, unnecessary elimination diets, targeted specific IgE testing, testing with allergen component, nutritional risk, emergency department utilization, pharmacoequity, food insecurity screening, and community resources. Clinicians will learn practical ways to identify barriers affecting their patients, refine food allergy diagnoses, reduce unnecessary food avoidance, and connect families with appropriate nutrition, social, and specialty resources. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/food-allergy-disparities-food-insecurity-primary-care.html?cid=0ct_3pc_05032024_9SGOV4
    続きを読む 一部表示
    26 分
  • The Microbiome and Allergy: What Primary Care Should Know
    2026/08/25
    About 30% to 40% of the world’s population is affected by some form of allergic disease, making allergy a routine consideration in primary care. But as interest in the microbiome grows, clinicians and patients face an important question: what does the evidence actually tell us about its role in allergic disease? This episode explores immune development, the hygiene and biodiversity hypotheses, food allergy, early-life tolerance, the gut-skin axis, atopic dermatitis, asthma, allergic rhinitis, antibiotic exposure, diagnostic testing, and early peanut introduction. The discussion separates established evidence from emerging associations and considers what, if anything, should change in clinical practice today. Clinicians will come away with practical guidance on maintaining evidence-based allergy diagnosis and management while understanding where microbiome research may shape future approaches to prevention and care. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/microbiome-and-allergy-what-primary-care-should-know.html?cid=0ct_3pc_05032024_9SGOV4
    続きを読む 一部表示
    35 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません